A major pharmaceutical province intends to issue guidance

May 7, in order to further promote the healthy and orderly development of the modern logistics industry of pharmaceuticals, promote the large-scale and standardized development of pharmaceutical circulation enterprises, and ensure the quality and safety of drugs in the logistics sector, the Shanghai Municipal Drug Administration issued a notice on the "Shanghai Drug Modern Logistics Guidance (Draft for Comments)" for public consultation.The Opinions clearly define the institutions and personnel, quality management and system, facilities and equipment, information management system, system and management of third-party logistics enterprises. Industry insiders believe that this may be other provinces and cities of modern drug logistics work to promote the role, and even further accelerate the standardization of China's pharmaceutical logistics construction.In fact, as an important part of modern logistics, pharmaceutical logistics, with the rapid development of the pharmaceutical market in recent years, has also entered a period of opportunity for development. Data show that in 2017, China's total pharmaceutical logistics amounted to 3.02 trillion yuan, an increase of 11.3% year-on-year. It is expected that by 2020, the total amount of pharmaceutical logistics will reach 3.8 trillion yuan. In addition, the state cancelled the third party engaged in drug logistics business administrative approval, encourage large pharmaceutical commercial circulation enterprises with a complete quality system to open their logistics resources to all parties in the supply chain, improve the efficiency of pharmaceutical logistics, the market in fact, there is room for further growth.From the above data, China's pharmaceutical logistics market will gradually grow in size, growth space is considerable. However, from the point of view of drug quality and safety, many logistics enterprises lack professional knowledge and personnel in medicine transportation, storage, management and so on, there are greater risks in the process of medical transportation, it is difficult to ensure the standardization of transportation and drug safety.Therefore, in recent years, in order to strengthen the compliance of the pharmaceutical transport control system to establish and improve, further reduce the risk of pharmaceutical logistics and transportation, to ensure the quality and safety of drugs. Provinces and cities have also promoted the development of third-party pharmaceutical logistics on the basis of a series of policies to strengthen its norms and supervision. For example, in September 2019, the Liaoning Provincial Drug Administration issued the Measures for optimizing the integration of warehousing and transportation resources of modern pharmaceutical logistics enterprises in Liaoning Province, indicating that it will take a number of measures to promote the integration of storage and distribution resources between drug retail chains and modern logistics enterprises.Among them, it is worth noting that the Implementation Measures clearly state that the headquarters of retail chain enterprises handling entrusted storage and distribution of drugs can apply to the drug regulatory department as long as they undertake to meet the basic conditions, without on-site inspection, they can carry out this business; However, in order to ensure the quality of drugs, the drug regulatory department will carry out dynamic management of the entrusted storage and distribution of pharmaceutical business, and continue to strengthen the supervision of enterprises of both sides to meet the basic conditions, found that enterprises have significant risks and hidden dangers, will require them to immediately terminate the business.Also in June 2019, the Fujian Provincial Drug Administration issued a Notice on Strengthening the Supervision of Third-Party Logistics of Pharmaceuticals, and at the same time issued the Guide, which clearly defines the institutions and personnel, quality management and systems, facilities and equipment, and information management systems of third-party logistics.In general, with the expansion of the pharmaceutical logistics market, its entry into standardized development will be an inevitable trend. The industry expects that China's pharmaceutical logistics industry in the coming period will usher in a variety of standards issued by the eruption period. In this case, the relevant pharmaceutical distribution enterprises need to pay timely attention to policy changes, more and more regular development. (
pharmaceutical
network)
)